Table of Contents

Reviews

• Open Access

  Pulmonary arterial hypertension: tailoring treatment to risk in the current era

  Sean Gaine, Vallerie McLaughlin

  European Respiratory Review 26 (146) 170095; DOI: 10.1183/16000617.0095-2017 Published 20 December 2017
• Open Access

  Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled

  Anna R. Hemnes, Marc Humbert

  European Respiratory Review 26 (146) 170093; DOI: 10.1183/16000617.0093-2017 Published 20 December 2017
• Open Access

  The changing landscape of chronic thromboembolic pulmonary hypertension management

  Michael Madani, Takeshi Ogo, Gérald Simonneau

  European Respiratory Review 26 (146) 170105; DOI: 10.1183/16000617.0105-2017 Published 20 December 2017
• Open Access

  Advanced pulmonary arterial hypertension: mechanical support and lung transplantation

  Sonja Bartolome, Marius M. Hoeper, Walter Klepetko

  European Respiratory Review 26 (146) 170089; DOI: 10.1183/16000617.0089-2017 Published 20 December 2017
• Open Access

  Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice

  Stephen Y. Chan, Lewis J. Rubin

  European Respiratory Review 26 (146) 170094; DOI: 10.1183/16000617.0094-2017 Published 20 December 2017
• Open Access

  Is mitochondrial dysfunction a driving mechanism linking COPD to nonsmall cell lung carcinoma?

  Francois Ng Kee Kwong, Andrew G. Nicholson, Celeste L. Harrison, Philip M. Hansbro, Ian M. Adcock, Kian Fan Chung

  European Respiratory Review 26 (146) 170040; DOI: 10.1183/16000617.0040-2017 Published 25 October 2017
• Open Access

  COPD in individuals with the PiMZ alpha-1 antitrypsin genotype

  Haitham S. Al Ashry, Charlie Strange

  European Respiratory Review 26 (146) 170068; DOI: 10.1183/16000617.0068-2017 Published 25 October 2017
• Open Access

  Lung segmentectomy: does it offer a real functional benefit over lobectomy?

  Anne Charloux, Elisabeth Quoix

  European Respiratory Review 26 (146) 170079; DOI: 10.1183/16000617.0079-2017 Published 25 October 2017
• Open Access

  Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease

  Rana Kanaan, Charlie Strange

  European Respiratory Review 26 (146) 170061; DOI: 10.1183/16000617.0061-2017 Published 25 October 2017
• Open Access

  Current and new challenges in occupational lung diseases

  Sara De Matteis, Dick Heederik, Alex Burdorf, Claudio Colosio, Paul Cullinan, Paul K. Henneberger, Ann Olsson, Anne Raynal, Jos Rooijackers, Tiina Santonen, Joaquin Sastre, Vivi Schlünssen, Martie van Tongeren, Torben Sigsgaard on behalf of the European Respiratory Society Environment and Health Committee

  European Respiratory Review 26 (146) 170080; DOI: 10.1183/16000617.0080-2017 Published 15 November 2017
• Open Access

  Inhaler technique: does age matter? A systematic review

  Sarah Barbara, Vicky Kritikos, Sinthia Bosnic-Anticevich

  European Respiratory Review 26 (146) 170055; DOI: 10.1183/16000617.0055-2017 Published 6 December 2017
• Open Access

  Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis

  Lisa H. Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera, Steven D. Nathan, Marlies S. Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessler, Ulrich Costabel

  European Respiratory Review 26 (146) 170057; DOI: 10.1183/16000617.0057-2017 Published 6 December 2017
• Open Access

  Long-term macrolides in diffuse interstitial lung diseases

  Paola Faverio, Francesco Bini, Adriano Vaghi, Alberto Pesci

  European Respiratory Review 26 (146) 170082; DOI: 10.1183/16000617.0082-2017 Published 6 December 2017